Associations of Sensory and Motor Functions in Midlife with Longitudinal Blood‐Based Biomarker Levels of Alzheimer’s Disease and Neurodegeneration

Dementia has a long preclinical phase and pathological fluid biomarker levels change decades before clinical symptoms. Thus, early detection of people at risk for neurodegenerative and pathological changes, especially in midlife, might improve future treatments and preventions. Sensory and motor changes are common in aging adults and may be early markers of neurodegeneration since they are associated with cognition and risk factors of neurodegeneration. However, their associations with blood‐based neurodegenerative and AD biomarkers are not yet known. We aimed to determine if midlife sensory and motor functions are associated with long‐term changes in blood‐based biomarkers of neurodegeneration and AD (neurofilament light chain(NfL), total tau(TT), and amyloid beta(Aβ)).